Indaptus Therapeutics Inc.
13F holders, Q1 2025 (March 31)19holders −1
1new positions
2sold out
1famous investor
$0.55avg. 13F price*
At the end of Q1 2025, 19 institutions reported holding Indaptus Therapeutics Inc. in their 13F filings, down 1 from Q4 2024. 1 opened new positions and 2 sold out. The largest holders were Vanguard Group Inc. ($141K), Investment House LLC ($71K) and Geode Capital Management, LLC ($69K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Indaptus Therapeutics Inc.
- CUSIP
- 45339J105
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $7K |
| Exits | 2 | $29K |
All 13F filers, Q4 2024 → Q1 2025: 85,733 shares bought and 37,107 shares sold, net +48,626 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Vanguard Group Inc. | 0.00% | No change | 256,265 | $141K |
| Investment House LLC | 0.00% | Add +28.6% | 128,851 | $71K |
| Geode Capital Management, LLC | 0.00% | Add +52.2% | 124,967 | $69K |
| Strategy Asset Managers LLC | 0.01% | No change | 45,336 | $25K |
| Pine Valley Investments Ltd Liability Co | 0.00% | Reduce -0.3% | 43,771 | $24K |
| Renaissance Technologies | 0.00% | Add +2.9% | 28,500 | $16K |
| Debussy Capital Management LP | 0.00% | No change | 24,000 | $13K |
| State Street Corp. | 0.00% | No change | 13,073 | $7K |
| Virtu Financial LLC | 0.00% | New | 12,872 | $7K |
| SBI Securities Co., Ltd. | 0.00% | Add +12.8% | 4,400 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.6% | 3,493 | $2K |
| Morgan Stanley | 0.00% | No change | 884 | $486 |
| Bangor Savings Bank | 0.00% | Reduce -12.5% | 350 | $192 |
| Bank of America Corp. | 0.00% | Add +60.7% | 98 | $54 |
| UBS Group AG | 0.00% | Reduce -96.5% | 87 | $49 |
| Wells Fargo & Company | 0.00% | No change | 64 | $35 |
| JPMorgan Chase & Co. | 0.00% | Reduce -10.5% | 17 | $9 |
| Group One Trading LLC | 0.00% | No change | 7 | $4 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is INDAPTUS THERAPEUTICS INC's weight in each manager's 13F, not the share of Indaptus Therapeutics Inc. the manager owns.